Media Information
iHealth Connections Next issue – Vol 2 Issue 1
Exploring the opportunities and challenges in the rapidly emerging field of health sciences as the growing movement towards intelligent, personalized healthcare provision blurs the boundaries between the healthcare and life sciences sectors.
|
| Touch Health Sciences are pleased to welcome Craig Lipset, Head of Clinical Innovation, Worldwide Research & Development, Pfizer Inc. to the role of Guest Editor-in-Chief for this exciting issue.
Joining Craig Lipset will be Charlene S Underwood, Board Chair, HiMSS and Charles Jaffe, CEO, HL7 onto our Editorial Board, which includes expert voices from advisory and stakeholder organisations.
This latest journal will mirror the Annual DIA conference theme of ‘Collaborate to Innovate’ while focusing on the following areas: mHealth and the use of mobile for novel data capture; crowdsourcing; telemedicine and virtual trials aiding new patient engagement in research – all acting as enablers of research collaboration. |
|
|
iHealth Connections is distributed by across channels and multiple platforms to a global audience of more than 100,000 Senior Healthcare and Life Sciences professionals
|
Publication date |
|
End May 2011 |
Content/collaboration deadline |
|
Mid March 2012 |
Advertising deadline |
|
End March 2012 |
|
www.touchhealthsciences.com
Touch Health Sciences – Leading the discussion on healthcare and life sciences innovation
The boundaries of the life sciences and healthcare sectors are merging to create new healthcare solutions for patients and providers, and new partnership models for life sciences companies to work together. The aim is to integrate clinical, operational, and financial data to improve health care services, enhance product development, reduce risk, and manage resources throughout the whole healthcare supply chain. Touch Health Sciences comprises drug development journals, bespoke web content and reports for companies leading health innovations, and aims to provide insight for thought leaders in pharmaceutical, biotechnology and medical device companies globally. |
